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Why was the cohort set up?
Non-communicable chronic diseases are the leading cause
of death and the main contributor to disease burden world-
wide, accounting for 86% of all deaths in Portugal.1 Several
modifiable behavioural risk factors, such as unhealthy die-
tary habits, physical inactivity, tobacco use and harmful use
of alcohol, are the main risk factors for these diseases. Thus,
the existence of epidemiological data on chronic diseases
and their determinants (i.e. socioeconomic and demographic
factors), associated factors and consequences are important
public health tools for designing and developing strategies
to tackle the burden of non-communicable diseases.
In 2011, a prospective cohort study called Epidemiology of
Chronic Diseases (EpiDoC) aimed to create a large population
database for medical and health-related research in Portugal.
To our knowledge, the EpiDoC study constitutes one of the
first Portuguese prospective large cohort studies, including a
representative sample of the Portuguese population, with the
primary aim of examining the health determinants and out-
comes of chronic non-communicable diseases and their impact
on health care resource consumption. The EpiDoC study was
designed by researchers from NOVA Medical School in
Lisbon with close collaboration between social and biomedical
scientists, ensuring a thorough multidisciplinary approach.
The first wave of this cohort study, named EpiDoC 1
(EpiReumaPt), occurred between September 2011 and
December 2013. Its primary aim was to assess rheumatic and
musculoskeletal disease (RMD) prevalence and its burden in
Portugal. This wave had two phases: the first consisted of a
face-to-face interview, and the second included a detailed clin-
ical evaluation of RMD performed by rheumatologists. This
baseline assessment also enabled the creation of a population-
based biobank (i.e. DNA, serum and total blood samples) for
identifying genetic predictors and serum risk factors for
chronic diseases. Musculoskeletal imaging data were also col-
lected, in particular peripheral dual energy X-ray (DXA) in all
second phase participants and X-ray of the affected joint(s).
Similar to other cohort studies,1,2 the scope of the
EpiDoC study has expanded over time. So far, two subse-
quent waves have been completed: EpiDoC 2 (March 2013–
July 2015) and EpiDoC 3 (September 2015–July 2016). In
both waves, data were collected through a phone interview.
EpiDoC 2 (CoReumaPt) focused on lifestyle behaviours and
their determinants, with a secondary goal of identifying in-
novative patient solutions for coping with disability.
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EpiDoC 3 (Sau´de.Come) assessed inequalities in access to
healthy food and health services, with a focus on food inse-
curity and its determinants and health consequences.
The EpiDoC study was performed according to the
principles established by the Declaration of Helsinki and
revised in 2013 in Fortaleza. Ethical approval was
obtained from the National Committee for Data
Protection (Comiss~ao Nacional de Protec¸~ao de Dados) and
NOVA Medical School Ethics Committee. Ethical commit-
tees of regional health authorities also approved the study.
Who is in the cohort?
Setting
EpiDoC is a prospective closed cohort study including a na-
tionally representative sample of adults (18 years old)
who were non-institutionalized and living in private house-
holds in Portugal Mainland and Islands (Azores and
Madeira).3 Portugal is a south-western European country
with a resident population of 10 562 178, of whom 8 mil-
lion are adults (4 072 122 men and 4 585 118 women).4
During the past two decades, life expectancy in Portugal
has been increasing. Data from the World Health
Organization indicate that life expectancy in Portugal was
83.9 years for women and 78.2 years for men in 2015. In
addition, as in other European countries, the Portuguese
population has been undergoing demographic changes. The
Portuguese population pyramid shows an increasing num-
ber of individuals at the top and a decreasing number at the
bottom, indicating a new structure of the Portuguese popu-
lation with fewer young people and more elderly. In 2015,
the old-age dependency ratio was 31.1 per 100 persons of
working age, which is the ratio between the number of per-
sons aged 65 years (i.e. when individuals are generally
economically inactive) and those aged 15–64 years.5
Portugal is divided into seven regions according to the
Nomenclature of Territorial Units for Statistics II (NUTS
II): Norte, Centro, Lisboa e Vale do Tejo, Alentejo,
Algarve, Regi~ao Auto´noma dos Ac¸ores (the Azores) and
Regi~ao Auto´noma da Madeira (Madeira). At the NUTS II
level, the Norte region has the largest population density
(34.7%), followed by Lisboa e Vale do Tejo (26.6%) and
Centro (22.4%) (Figure 1). The other NUTS II regions
(Alentejo, Algarve, the Azores, and Madeira) encompass
small towns and villages with lower population densities
and higher desertification rates.
Participant recruitment
Considering the primary aim of EpiDoC 1, the sample size
was calculated based on the estimated prevalence of rheu-
matic diseases with a 95% confidence interval (CI), and
standardized for age and sex according to the total adult
population of the studied areas. Assuming that the
expected prevalence of rheumatic diseases was between
0.5% and 1%, and expecting a drop-out rate of 50%, it
was estimated that a total of 9000 individuals should be
recruited. To obtain regional representativeness, the sam-
ple size was stratified according to dimensions and charac-
teristics of the seven Portuguese regions. Population
recruitment was conducted by Centro de Estudos e
Sondagens de Opini~ao da Universidade Cato´lica
Portuguesa (CESOP-UCP), and multistage random sam-
pling was used for participant selection.
In EpiDoC 1, candidates for participation were visited at
their homes by a team of trained interviewers. Locations
were selected as the primary unit of sampling according to
the Census 2001. Selected households and their addresses
were identified using a random selection of points in the
map of each location, where the interviewer began a sys-
tematic step count (defined for each locality based on its
size). Each selected household was visited, with no previous
contact, up to three times (including evenings and week-
ends) if no candidate participant was present during the
first visit. In each household, an individual 18 years old
with permanent residence and the most recently completed
birthday was selected to be a participant in the EpiDoC
study. Before participant interviews, the EpiDoC team gave
information about study details and aims at local churches,
primary care centres and municipalities. Local priests,
health providers and municipality employers helped us to
spread the information and motivate participation.
Figure 1. Portuguese population density distribution according to the 7
NUTS II.
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EpiDoC 1 (2011–13)
EpiDoC 1 enrolled 10 661 participants and was primarily
designed to estimate the prevalence of RMDs. To provide
a comprehensive understanding of the burden of RMDs,
this wave had the secondary aim of evaluating quality of
life, physical function, mental health, work status and
health care resource consumption, with the purpose of
identifying differences in these and other outcomes
between individuals with and without RMDs.3
EpiDoC 1 data collection consisted of two phases.
Phase 1 involved face-to-face interviews conducted by a
team of trained interviewers (non-physicians) through
door-to-door visits. Phase 2 involved clinical observations
with physical examination performed by rheumatologists,
for participants identified as potentially having an RMD
(using a screening questionnaire applied at Phase 1) and
20% of asymptomatic individuals. All procedures occurred
between September 2011 and December 2013.
Of the 10 661 participants selected in Phase 1, 7451
had a positive RMD screening and 3210 had a negative
RMD screening. A total of 8152 participants were
contacted in Phase 2: 7451 with a positive RMD and
701 (20%) without an RMD as previously defined in the
study protocol. Of these, 4275 did not attend a clinical
observation by a rheumatologist. Therefore, at the end of
Phase 2, there were 3877 clinical observations with physi-
cal examination performed by rheumatologists; 3198
participants received validation of an RMD diagnosis and
679 did not have an RMD diagnosis.
In Phase 1, a structured questionnaire using a
computer-assisted personal interview (CAPI) system was
used to collect data. Questions on rheumatic symptoms
were asked, and an algorithm for screening each RMD was
applied. An individual was considered to have a positive
screening: if he/she mentioned a previously known RMD;
if any of the specific disease algorithms in the screening
questionnaires were positive; or if the participant reported
muscle, vertebral or peripheral joint pain in the previous
4 weeks.3 Phase 2 was performed by rheumatologists at the
local primary care centre for all participants who were
identified as having a positive RMD screening. All clinical
laboratory and imaging data were verified by a team of
three experienced rheumatologists, and diagnoses were
confirmed according to validated criteria.3
All participants enrolled in EpiDoC 1 (10 661 partici-
pants) were invited to participate in a follow-up study, of
whom 10 153 (95.2%) signed consent forms and agreed to
participate. For follow-up waves (EpiDoC 2 and 3), data
were collected using a structured questionnaire adminis-
tered by phone call interviews using a CAPI system. A core
questionnaire was used in each EpiDoC wave, with
additional questions added according to the focus of each
wave. In EpiDoC 2 and 3, when a participant was not
available, additional attempts were made at different times
up to a maximum of six attempts. The last contact attempt
had to follow the previous contact by least 1 month; only
then was the contact attempt abandoned.
EpiDoC 2 (2013–15)
EpiDoC 2 was the first follow-up wave, with data collected
between March 2013 and July 2015. EpiDoC 2 included
7591 participants (out of 10 153 eligible participants) rep-
resentative of the adult Portuguese population, resulting in
a response rate of 71.2% from EpiDoC 1. Considering that
the main risk factors for non-communicable diseases are
unhealthy lifestyle behaviours, EpiDoC 2 employed the
core structured questionnaire but included more detailed
questions on lifestyle behaviours, such as physical activity,
dietary habits, tobacco and alcohol use and sleeping habits.
Questions regarding innovative patient solutions for cop-
ing with disability were also included.
EpiDoC 3 (2015–16)
EpiDoC 3 occurred between September 2015 and July
2016 and included 5653 participants, resulting in a re-
sponse rate of 55.7% from EpiDoC 1. This wave contin-
ued to employ the core structured questionnaire but
included questions on food insecurity, its determinants and
its health consequences. This particular interest in food in-
security was based on a growing awareness of social
inequalities in health and modifiable risk factors for
chronic diseases, such as dietary patterns, as well as the
economic crisis faced by Portugal in previous years.
Cohort characteristics
The participation rate declined from EpiDoC 1 to EpiDoC
3, similar to most other population-based studies.2,6
Table 1 presents the characteristics of participants in the
cohort. There were no significant differences in any catego-
ries of variables between the three waves.
How often have they been followed up?
The EpiDoC study employed cross-sectional and longitudi-
nal study designs (Figure 2). As it used a closed cohort, no
new participants were added in any wave. Table 2 presents
the attrition rates between EpiDoC 1 and 2, EpiDoC 1 and
3, and EpiDoC 2 and 3.
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Table 1. Characteristics of the participants in the cohort
EpiDoC 1 EpiDoC 2 EpiDoC 3 Census 2011
Sex n¼10 661 n¼7591 n¼5653 n¼8 657 240
Female 6551 (52.6%) 4784 (52.2%) 3607 (52.5%) 4 585 118 (53.0%)
Age group n¼10 661 n¼7591 n¼5648
18–29 1182 (22.1%) 621 (18.4%) 355 (15.4%) 1 470 782 (17.0%)
30–39 1511 (18.8%) 975 (18.7%) 605 (19.1%) 1 598 250 (18.5%)
40–49 1906 (17.3%) 1437 (18.2%) 1049 (18.3%) 1 543 392 (17.8%)
50–59 1801 (14.8%) 1437 (16.2%) 1143 (15.9%) 1 400 011 (16.2%)
60–69 1915 (12.9%) 1440 (13.2%) 1112 (13.7%) 1 186 442 (13.7%)
70–74 849 (5.8%) 645 (6.2%) 491 (6.7%) 496 438 (5.7%)
75 1497 (8.4%) 1036 (9.1%) 893 (11.0%) 961 925 (11.1%)
Ethnicity/race n¼10 629 n¼7574 n¼5638
Caucasian 10 342 (96.0%) 7423 (97.1%) 5536 (97.2%) No comparable data
Black 221 (3.4%) 119 (2.5%) 81 (2.3%)
Asian 8 (0.1%) 3 (0.0%) 2 (0.1%)
Romany 20 (0.3%) 7 (0.1%) 5 (0.1%)
Other 38 (0.3%) 22 (0.3%) 14 (0.3%)
Years of education
(mean6 SD) 7.41 6 4.1 8.66 6 3.90 8.80 6 3.94
Education level n¼10 585 n¼7546 n¼5615
0–4 years 4726 (33.2%) 3272 (31.7%) 2392 (30.9%) 3 239 724 (37.4%)
5–9 years 2175 (22.6%) 1547 (21.3%) 1122 (19.6%) 2 134 401 (24.6%)
10–12 years 1920 (23.8%) 1391 (24.8%) 1049 (25.6%) 1 560 958 (18.0%)
>12 years 1764 (20.4%) 1336 (22.2%) 1052 (24.0%) 1 741 567 (20.1%)
NUTS II n¼10 661 n¼7591 n¼5648
Norte 3122 (34.9%) 2240 (35.8%) 1659 (36.5%) 3 007 823 (34.7%)
Centro 1997 (22.8%) 1504 (23.3%) 1087 (23.2%) 1 938 815 (22.4%)
Lisboa 2484 (26.7%) 1588 (25.4%) 1131 (24.8%) 2 300 053 (26.6%)
Alentejo 669 (7.3%) 422 (7.2%) 320 (7.2%) 633 691 (7.3%)
Algarve 352 (3.8%) 245 (3.8%) 183 (3.7%) 370 704 (4.3%)
Azores 1029 (2.2%) 793 (2.1%) 657 (2.5%) 192 357 (2.2%)
Madeira 1008 (2.3%) 799 (2.4%) 611 (2.4%) 213 797 (2.5%)
Marital status n¼10 652 n¼7586 n¼5644
Single 1935 (29.4%) 1285 (28.4%) 922 (28.5%) No comparable data
Married 6111 (50.2%) 4591 (53.2%) 3457 (53.4%)
Divorced 810 (7.4%) 556 (6.8%) 391 (6.1%)
Widow(er) 1414 (8.2%) 910 (7.3%) 697 (7.6%)
Consensual union 382 (4.8%) 244 (4.2%) 177 (4.4%)
BMI n¼10 109 n¼6922 n¼5174
Underweight 167 (2.2%) 111 (2.0%) 88 (2.1%) No comparable data
Normal 4063 (45.5%) 2670 (45.5%) 2009 (44.5%)
Overweight 3799 (35.1%) 2788 (37.1%) 2098 (37.7%)
Obese 2080 (17.1%) 1353 (15.4%) 979 (15.7%)
Monthly household income n¼7613 n¼5558 n¼4167
<500e 1994 (19.9%) 1331 (18.0%) 945 (16.66%) No comparable data
501e to 750e 1707 (21.7%) 1257 (20.8%) 949 (20.91%)
751e to 1000e 1268 (18.8%) 943 (19.0%) 717 (19.89%)
1001e to 1500e 1141 (17.2%) 852 (17.5%) 638 (16.97%)
1501e to 2000e 657 (9.9%) 511 (10.9%) 386 (11.08%)
2001e to 2500e 379 (5.9%) 295 (5.7%) 246 (6.37%)
2501e to 3000e 222 (3.0%) 188 (3.8%) 148 (3.98%)
3001e to 4000e 146 (1.8%) 108 (2.1%) 83 (1.94%)
>4000e 99 (1.9%) 73 (2.2%) 55 (2.20%)
SD, standard deviation.
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Loss to follow-up
The participation rate in EpiDoC 3 was of 53.03%. The attri-
tion was most pronounced in younger adults (18–29years
old). Of the 10 661 participants in EpiDoC 1,509 (4.8%) re-
fused to sign the consent form for follow-up. Of the resulting
10 153 eligible participants for EpiDoC 2, 79 (0.8%) had
died, 179 (1.8%) wished to leave the study and 917 (9.0%)
had an invalid contact. Thus, a total of 1639 participants were
lost to follow-up; these subjects had a mean age of 55years,
and 962 (58.7%) were women. Between EpiDoC 2 and 3, 51
(0.6%) participants had died, 232 (2.6%) wished to leave the
study and 721 (8.0%) had an invalid contact. Thus, a total of
1004 participants were lost to follow-up; these individuals had
a mean age of 56 years, and 620 (61.8%) were women.
Figure 1 shows the flowchart of the EpiDoC study.
What has been measured?
Data collection included measures for five domains that
were central to the longitudinal study: sociodemographic
characteristics, lifestyle characteristics, health and clinical
characteristics, health care resource consumption, a
population-based biobank (total blood, serum and DNA)
and imaging data (peripheral DXA and X-ray of the af-
fected joint) (Table 3). For reasons of longitudinal compar-
ison, most measurement tools were used consistently
across waves. However, some measurement tools were
updated or improved, new measurement tools were added
and old measurement tools were removed as needed.
Of the measurements obtained across all three waves,
lifestyle variables included smoking habits, alcohol intake
and physical exercise. Health variables included anthropo-
metric measures, self-reported chronic diseases, rheumatic
diseases, a health assessment questionnaire (HAQ)7 and
the European Quality of Life Survey with five dimensions
and three levels (EQ-5D-3L).8,9 Employment variables in-
cluded employment status, retirement due to disease, re-
tirement due to RMD, work absenteeism due to disease,
work disability due to RMD, unemployment due to dis-
ease, unemployment due to RMD, number of working
hours/week and changed employment status due to RMD.
Health care resource variables included hospitalization
events (in previous 12 months since last contact), their rea-
son and their duration. Concerning falls and bone frac-
tures, variables included any falls or bone fractures and the
number and location of bone fractures. Sociodemographic
data, including sex, age, ethnicity, years of education and
education level, and marital status, were collected only in
EpiDoC 1, based on the assumption that these characteris-
tics would not change over time. Other information
obtained only in EpiDoC 1 were household income, house-
hold composition, coffee intake and health information
from the 36-item Short Form Survey (SF-36).10
Information obtained only in EpiDoC 1 and 2 were the
Hospital Anxiety and Depression Scale (HADS)11 and
home care assistance (in previous 12 months or since last
contact), its provider and its payer.
Information obtained only in EpiDoC 2 and 3 included:
sleep habits; frequency of watching TV, using computer/
videogames/tablets and using the internet; number of meals
per day; frequency of soup, vegetable, fruit, meat, fish,
milk/dairy and water consumption; numbers of medical
appointments (in previous 12 months or since last contact),
private versus public medical appointments, private medi-
cal appointments with or without insurance, public medi-
cal appointments in a hospital/health care centre and
private or public medical appointments by specialty.
Information obtained only in EpiDoC 3 were frequency
of olive oil, wine, beans, fat and sugar consumption; atti-
tudes toward food; a food insecurity scale; and characteris-
tics of food acquisition and preparation.
Population-based biobank and imaging data were col-
lected in EpiDoC 1 during medical appointments at the lo-
cal primary care centre. Blood samples were collected from
3608 participants (DNA, serum and whole blood). Taking
into consideration the imaging reservoir, there were a total
of 3342 participants who had a forearm bone mineral den-
sity evaluation through peripheral DXA. Also, bone min-
eral assessment (BMA) using a high-resolution digital X-
ray machine (D3A, France) was collected from 2422 wrists
and 2228 calcaneus bones. Simple X-rays were performed
to examine 438 hands, 122 hips, 479 knees, 1265 lumbar
spines, 691 thoracic spines and 206 cervical spines, accord-
ing to participants’ musculoskeletal complaints. All data
collected, including biobank and imaging data, are detailed
in Table 3.
Figure 2. Flowchart of EpiDoC study.
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Table 2. Characteristics of the participants in the cohort (attrition rate)
EpiDoC 1 vs
EpiDoC2 (attrition rate)
EpiDoC 2 vs
EpiDoC3 (attrition rate)
EpiDoC 1 vs
EpiDoC3 (attrition rate)
Total 28.80% 25.53% 46.97%
Sex
Female 26.97% 24.60% 44.94%
Age group
18–29 47.46% 42.83% 69.97%
30–39 35.47% 37.95% 59.96%
40–49 24.61% 27.00% 44.96%
50–59 20.21% 20.46% 36.54%
60–69 24.80% 22.78% 41.93%
70–74 24.03% 23.88% 42.17%
75 30.79% 13.80% 40.35%
Ethnicity/race
Caucasian 28.22% 25.42% 46.47%
Black 46.15% 31.93% 63.35%
Asian 62.50% 33.33% 75.00%
Romany 65.00% 28.57% 75.00%
Other 42.11% 36.36% 63.16%
Education level
0–4 years 30.77% 26.89% 49.39%
5–9 years 28.87% 27.47% 48.41%
10–12 years 27.55% 24.59% 45.36%
>12 years 24.26% 21.26% 40.36%
NUTS II
Norte 28.25% 25.94% 46.86%
Centro 24.69% 27.73% 45.57%
Lisboa 36.07% 28.78% 54.47%
Alentejo 36.92% 24.17% 52.17%
Algarve 30.40% 25.31% 48.01%
Azores 22.93% 17.15% 36.15%
Madeira 20.73% 23.53% 39.38%
Marital status
Single 33.59% 28.25% 52.35%
Married 24.87% 24.70% 43.43%
Divorced 31.36% 29.68% 51.73%
Widow(er) 35.64% 23.41% 50.71%
Consensual union 36.13% 27.46% 53.66%
BMI
Underweight 33.53% 20.72% 47.31%
Normal 34.29% 24.76% 50.55%
Overweight 26.61% 24.75% 44.77%
Obese 34.95% 27.64% 52.93%
Monthly household income
<500e 33.25% 29.00% 52.61%
501e to 750e 26.36% 24.50% 44.41%
751e to 1000e 25.63% 23.97% 43.45%
1001e to 1500e 25.33% 25.12% 44.08%
1501e to 2000e 22.22% 24.46% 41.25%
2001e to 2500e 22.16% 16.61% 35.09%
2501e to 3000e 15.32% 21.28% 33.33%
3001e to 4000e 26.03% 23.15% 43.15%
>4000e 26.26% 24.66% 44.44%
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Table 3. Data collected over EpiDoC study
EpiDoC 1
EpiReumaPt (CESOP)
10 661
EpiDoC 1 EpiReumaPt
(medical appointments)
3877
EpiDoC 2
CoReumaPt
7591
EpiDoC 3
Sau´de.Come
5653
Sociodemographic and economic data
Sex X
Age X
Ethnicity X
Nationality X
Years of education and educational level X
Marital status X
Employment status X X X
Household income X X
Household composition X X
Number of people <18 y in household X X
Number of people >65 y in household X
Region (NUT II) X
Location and district X
Home & neighbourhood characteristics X
Single-parent families X
Income perception X
Anthropometric data
Self-reported height (in cm) X X X X
Self-reported weight (in kg) X X X X
Body mass index (kg/m2) X X X X
Self-reported chronic diseases
High blood pressure, diabetes, high cholesterol level,
pulmonary disease, cardiac disease, gastrointestinal
disease, neurological disease, allergies, mental dis-
ease, neoplastic disease, thyroid and parathyroid
disease, hyperuricaemia and urinary disease
X X X X
Rheumatic diseases
Rheumatoid arthritis, spondyloarthritis, psoriatic
arthritis, osteoarthritis, osteoporosis, gout, poly-
myalgia rheumatica, systemic lupus erythematosus,
fibromyalgia, periarticular diseases, low back pain,
inflammatory low back pain, chondrocalcinosis
and other RMD
X X X X
Who diagnosed RMD X X X
Rheumatic complaints X X X X
Medical history X
Physical examination X
Anxiety, depression, physical function and quality of life
Hospital Anxiety and Depression Scale (HADS) X X
Health Assessment Questionnaire (HAQ) X X X
Short Form Health Survey (SF-36) X
European Quality of Life questionnaire (EQ-5D-3L) X X X
Falls and bone fractures
Suffered any fall, where the fall happened (home,
street, work), number of falls (home, street, work),
suffered any bone fracture, number of bone frac-
tures and location of bone fracture
X X X
Health and employment
Retired due to disease, retired due to RMD, work
absenteeism due to disease, work disabled due to
X X X
(Continued)
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What has it found? Key findings and
publications
Over 24 peer-reviewed journal publications based on
EpiDoC data have been published to date, covering a wide
range of scientific domains. A full list of publications can
be found on our website[http://cedoc.unl.pt/epidoc-unit/].
Sample overviews of study data are shown in Tables 1, 2
and 4. Here, we summarize key findings.
In EpiDoC 1, we characterized socioeconomic features
of the Portuguese adult population. From a social and
health point of view, an alarming finding was that one-
fifth of the adult Portuguese population had a monthly
Table 3. Continued
EpiDoC 1
EpiReumaPt (CESOP)
10 661
EpiDoC 1 EpiReumaPt
(medical appointments)
3877
EpiDoC 2
CoReumaPt
7591
EpiDoC 3
Sau´de.Come
5653
RMD, unemployed due to disease, unemployed
due to RMD, number working h/week and changed
employment status (past year) due to RMD
Health and economic
Chronic disease management difficulties, medication
non-adherence due to economic constraints, and re-
duction in visits to medical appointments due to
economic constraints
X
Hospitalizations, home care assistance and medical appointments
Was hospitalized (past 12 months/since last contact),
reason and duration of hospitalization, home care
assistance (past 12 months/since last contact, cur-
rently), who provides and who pays for home care
assistance, medical appointments (past 12 months/
since last contact), number private/public medical
appointments, private medical appointments with/
without insurance, public medical appointments in
hospital/health care centre, number private/public
medical appointments by specialty, health care sys-
tem (ADSE, subsystems, private insurance), medi-
cations and other treatments, medicine(s) currently
taking, other treatments (physical and rehabilita-
tion medicine, behavioural therapy etc.) and alter-
native treatments (acupuncture, homeopathy etc.)
X X X
Lifestyle data
Smoking habits (current/past smoker, number of ciga
rettes, smoking duration)
X X X
Alcohol intake (frequency, number of units) X X X
Coffee intake X
Physical exercise (frequency, type, age when started) X X X
Sleep habits (h/day) X X
Frequency of watching TV X X
Frequency of using computer/videogames/tablets X X
Frequency of using internet X X
Dietary intake and behaviours
Frequency of soup, vegetables, fruit, meat, fish,
milk/dairy, water consumption
X X
Adherence to Mediterranean diet X
Food insecurity X
Patient innovation to cope with disability X
Biobank and imaging data
Serum, whole blood, DNA, peripheral BMD (wrist),
X-ray of the affected joint (hand, hip, knee),
calcaneus and wrist BMA
X
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family income of <500e.3 Indeed, data from EpiDoC 2
showed that poverty and a low education level are associ-
ated with an unhealthy lifestyle and higher prevalence of
chronic diseases.12
Social inequality in health is a major concern within
public health, with food insecurity being one of its main
drivers. Food insecurity is defined as a difficulty in achiev-
ing a healthy diet due to economic constraints, and is a
well-known determinant of health. EpiDoC 3 showed a
high prevalence of food insecurity and its associations and
unhealthy dietary behaviours. Food insecurity was associ-
ated with several non-communicable diseases, lower qual-
ity of life and higher health care resource consumption.13
Publications using EpiDoC data have raised questions and
informed policy makers about the need to reduce food in-
security, not only to improve individual health status but
also to reduce public health costs.
Considering health and health-related characteristics,
high blood pressure, high cholesterol level, allergies and
RMDs were frequently self-reported among the Portuguese
adult population. The prevalence of RMDs in Portugal is
similar to that reported in other countries,14–19 namely
Portugal’s close neighbour Spain.20 Another interesting
finding was the high proportion of individuals presenting
typical features of one or more RMDs, who did not have a
previous diagnosis (1532 out of 3877 participants).21 This
could be explained by the scarce number of rheumatolo-
gists in Portugal (1: 100 000 inhabitants)22 and the lack of
awareness among the population about these diseases, as
RMD symptoms are frequently accepted as part of the nor-
mal ageing process. These results helped support a new na-
tional network for hospital reference of rheumatology,
developed by the National Directorate General of Health
in collaboration with the EpiDoC research team.
The RMD with the highest prevalence in Portugal was
low back pain (26.4%; 95% CI, 23.3-29.5%), which was
significantly more frequent in women than in men (29.6%
vs 22.8%; P¼ 0.040). Low back pain increased with age,
and its prevalence was highest in the 46–55-year age group
(27.7%; 95% CI 23.1-32.4%).21
Table 4. Prevalence and 95% of confidence interval of reported chronic diseases and lifestyle habits
EpiDoC 1 EpiDoC 2 EpiDoC 3
n¼10 661 n¼7591 n¼5653
Reported diseases
Chronic diseases n¼10 661 95% CI n¼7591 95% CI n¼5653 95% CI
High blood pressure 3369 (23.1%) 21.9–24.9 2538 (24.1%) 22.7–25.5 1872 (24.8%) 23.1–26.7
Diabetes 1217 (8.3%) 7.6–9.1 877 (8.6%) 7.8–9.5 690 (9.2%) 8.1–10.4
High cholesterol level 3360 (24.4%) 23.2–.25.7 2595 (25.9%) 24.5–27.4 1831 (25.3%) 23.6–27.2
Lung disease 637 (5.4%) 4.6–6.3 496 (5.7%) 4.8–6.7 213 (2.8%) 2.4–3.3
Cardiac disease 1366 (10.5%) 9.4–11.6 1034 (11.9%) 10.5–13.4 704 (9.8%) 8.7–11.1
Gastrointestinal disease 1837 (14.9%) 13.8–16.1 1411 (16.1%) 14.7–17.6 544 (8.8%) 7.6–10.3
Neurological disease 418 (3.3%) 2.8–3.9 311 (3.4%) 2.8–4.1 212 (2.9%) 2.4–3.4
Allergies 2287 (21.2%) 19.9–22.7 1720 (22.8%) 21.2–24.5 548 (10.3%) 8.6–12.3
Mental disease 1619 (12.9%) 11.7–14.1 1274 (14.1%) 12.4–16.0 1008 (13.4%) 12.3–14.5
Cancer 439 (3.4%) 2.8–4.2 364 (4.0%) 3.3–4.9 318 (4.6%) 3.8–5.5
Hyperuricaemia 690 (5.2%) 4.7–5.8 514 (5.4%) 4.8–5.9 130 (1.9%) 1.5–2.4
Renal colic 885 (7.0%) 6.4–7.8 716 (8.4%) 7.3–9.6 250 (4.3%) 3.4–5.4
Rheumatic disease 2994 (21.2%) 20.0–22.5 2552 (25.5%) 24.0–27.1 2096 (29.5%) 27.5–31.5
Lifestyle habits
Alcohol
Never 4625 (37.2%) 35.6–38.8 3150 (37.1%) 35.2–39.2 1945 (30.6%) 28.2–33.2
Occasionally 3967 (42.6%) 40.9–44.3 2437 (39.6%) 37.7–41.7 2020 (39.6%) 37.4–42.0
Daily 2050 (20.2%) 18.9–21.6 1693 (23.2%) 21.7–24.8 1565 (29.8%) 27.7–31.9
Smoking habits
Never/occasionally 8800 (76.8%) 75.1–78.4 4447 (54.4%) 52.3–56.4 3584 (58.8%) 56.3–61.3
Past smokinga Not applicable 1522 (21.1%) 19.6–22.6 1149 (21.1%) 19.4–23.0
Present smoker 1854 (23.2%) 21.6–24.9 1289 (24.5%) 22.4–26.7 802 (20.0%) 17.6–22.7
Physical activity
Regular 3499 (37.0%) 35.3–38.6 3442 (50.1%) 48.1–52.1 2147 (40.8%) 38.5–43.2
Not regular 7155 (63.0%) 61.3–64.6 3976 (49.8%) 47.9–51.9 3498 (59.2%) 56.8–61.5
aPast smoker was not included at baseline.
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Regarding the impact of RMDs on health-related qual-
ity of life, physical function and mental health among the
Portuguese population, EpiDoC data showed that patients
with RMDs have more health care resource consumption,
were more often hospitalized and had more homecare
support needs in the previous 12 months, compared with
participants with no RMDs.12,21,23 In EpiDoC 1, a mean-
ingful number (n¼ 488, 30.9%) of people claimed to have
retired prematurely due to RMDs.24 This translates to
many years of working life already lost and many others
still potentially lost. Indirect costs due to self-reported
RMDs are also substantial, equivalent to at least 0.5% of
the gross domestic product.21 These results emphasize the
burden of RMDs and the need to develop RMD awareness,
which is a strong argument encouraging policy makers to
increase the amount of resources allocated to the treatment
of rheumatic patients.
EpiDoC 1 also showed a high prevalence of other
chronic diseases among Portuguese adults such as dyslipi-
daemia (24.4–25.9%), hypertension (23.1–24.8%) and di-
abetes (7.6–9.1%). The elderly are a particularly
vulnerable population for chronic diseases, among whom
the coexistence of two or more chronic diseases is particu-
larly high (78.3%), leading to low quality of life and dis-
ability.25 The most common chronic diseases in the elderly
were hypertension (57.3%), rheumatic disease (51.9%),
hypercholesterolaemia (49.4%) and diabetes (22.7%).
Among older adults, 66.6% were physically inactive and
22.3% were obese, particularly among Azoreans (33.0%).
Similar results were found for Portuguese adults, of whom
more than half did not exercise (63.0%) and more than
15% were obese.25
EpiDoC 2 estimated a prevalence of anxiety and depres-
sion among Portuguese elderly of 9.6% and 11.8%,
respectively. Seniors with anxiety or depression were more
likely to self-report higher levels of physical disability and
lower quality of life.26
Biological and clinical data have been used in national
studies of older adult lifestyles,23,27 the impact of falls and
fractures, vitamin D level, sun exposure, dairy con-
sumption and oral health, as well as international collabo-
rative projects on mitochondrial DNA and BMA and bone
texture in osteoarthritis.28
In conclusion, EpiDoC publications have improved our
understanding of socioeconomic and health inequalities
among Portuguese adults, particularly the elderly. These
studies demonstrate that unhealthy lifestyles are more
prevalent among the most socioeconomically vulnerable
groups and are associated with a higher prevalence of
chronic non-communicable diseases and higher health care
resource consumption. The EpiDoC study has also shed
light on the burden of rheumatic diseases in Portugal.
It shows a need to rethink the rheumatology support
network and to provide better care to rheumatic patients.
EpiDoC ongoing work is aimed at revealing the determi-
nants and burden of multimorbidity and other chronic
non-communicable diseases, namely mental and cardiovas-
cular diseases. Particular attention will be directed at better
understanding unmet elderly health needs.
What are the main strengths and
weaknesses?
The main strengths of the EpiDoC study are its general
population base and sample size, availability of repeated
measures and extensive biobank blood collection. Another
strength is its interdisciplinary research cooperation, with
a team comprising physicians, psychologists, epidemiolo-
gists, nutritionists, statisticians, laboratory technicians and
others. The different purposes of the three waves are also a
strength, as they have expanded the scope of the EpiDoC
study to become a more complete cohort study.
The EpiDoC study also has some weaknesses, such as
its attrition rate, which is similar to that of other stud-
ies29,30 and was not significantly different between the
three waves. In EpiDoC 2 and EpiDoC 3, data were col-
lected by phone interviews; however, we attempted to re-
duce attrition bias by using reminders for scheduled visits
and sending periodic newsletters and reminders to all
participants. Another limitation is that diseases were
self-reported, although a detailed and comprehensive ques-
tionnaire included a screening for RMD symptoms. All
measurement tools (HADS, EQ-5D-3L, SF-36 and HAQ)
were validated and the screening of RMDs was validated
by an algorithm supplemented by expert rheumatologist
opinion. Each wave survey was composed of a structured
comprehensive questionnaire which was tested for feasibil-
ity, participant comprehension and language.3,12
Can I get hold of the data? Where can I find
more information?
The EpiDoC Unit promotes research networking—both
national and international—and develops collaborative
projects. Data from our cohort studies and projects are
freely available for researchers who submit a research pro-
posal to the scientific committee. More details about
questionnaire content and clinical measurements can be
found on our website [http://cedoc.unl.pt/epidoc-unit/].
A research proposal editable form can be downloaded
and sent to [rute.sousa@nms.unl.pt]. An EpiDoC steering
committee will evaluate all proposals for future studies
and collaborations, to access data and use of biological
samples.
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